Press Releases

Press Releases

Search Press Releases
  
Subscribe for Email Alerts
1/7/2019
8:30 AM ET
Press Release

Checkpoint Therapeutics Initiates Registrational Development Programs for Anti-PD-L1 Antibody CK-301

1/7/2019

NEW YORK, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, develo...

 Continue Reading
11/2/2018
8:00 AM ET
Earnings Release

Checkpoint Therapeutics Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights

11/2/2018

NEW YORK, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, develo...

 Continue Reading
10/16/2018
8:00 AM ET
Press Release

Checkpoint Therapeutics Appoints Christian Béchon to its Board of Directors

10/16/2018

NEW YORK, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, develo...

 Continue Reading
Displaying 1 to 5 (of 41 releases)